ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ASTRAZEN announcements Astrazeneca Pharma India Limited announcements and dividends declared NSE

Astrazeneca Pharma India Limited Complete list of announcements declared & dividend announcements by Astrazeneca Pharma India Limited ASTRAZEN

Astrazeneca Pharma India Limited ASTRAZEN listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Astrazeneca Pharma India Limited ASTRAZEN

AstraZeneca Pharma India surrenders marketing authorisation of prostate cancer drug
AstraZeneca Pharma India has voluntarily surrendered the marketing authorisation for its prostate cancer drug Olaparib (Lynparza) 100mg and 150mg in India, citing commercial reasons. The company clarified that the drug was never marketed in India since rec
Announcement as on 15 April 2025

Company Announcement
AstraZeneca Pharma India Limited has informed the Exchange about General Updates
Announcement as on 07 April 2025

Company Announcement
AstraZeneca Pharma India Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 '.
Announcement as on 24 March 2025

Company Announcement
AstraZeneca Pharma India Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015'.
Announcement as on 10 March 2025

AstraZeneca Pharma India gets CDSCO approval to import, sell cancer treatment medicine
AstraZeneca Pharma India has received approval from CDSCO to import and distribute the cancer treatment drug Durvalumab solutions. This approval allows the marketing of Durvalumab in combination with Tremelimumab for treating unresectable hepatocellular ca
Announcement as on 03 March 2025

Announcements by Astrazeneca Pharma India Limited first page | Next page | Prev page |

ASTRAZEN Astrazeneca Pharma India Limited current price & indicator signals

Moving Averages for Astrazeneca Pharma India Limited

  • 5Day Average: 8247.7
  • 12Day Average: 8388.08
  • 20Day Average: 8349.85
  • 50Day Average: 8439.24
  • 100Day Average: 8577.29
  • 150Day Average: 8782.47
  • 200Day Average: 8801.27

ASTRAZEN Indicators & signals

Indicator MACD (12,26,9)

8330.97, 8348.3, -5.99
Indicator MACD is in negative zone

Indicator ADX (14)

9.87, 17.26, 21.04
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ASTRAZEN Astrazeneca Pharma India Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
06 Wed May 2026 8382.50 8205.50 to 8400.50 1.88% 1.05 times
05 Tue May 2026 8228.00 8010.00 to 8239.50 2.26% 0.86 times
04 Mon May 2026 8046.00 8010.00 to 8310.00 -2.03% 1.85 times
30 Thu Apr 2026 8213.00 8102.00 to 8465.50 -1.86% 1.77 times
29 Wed Apr 2026 8369.00 8320.00 to 8549.00 -1.14% 1.02 times
28 Tue Apr 2026 8465.50 8426.50 to 8598.50 -1.25% 0.49 times
27 Mon Apr 2026 8573.00 8400.00 to 8599.00 0.86% 0.64 times
24 Fri Apr 2026 8500.00 8325.50 to 8594.00 0.51% 1.03 times
23 Thu Apr 2026 8456.50 8416.00 to 8544.00 0.2% 0.57 times
22 Wed Apr 2026 8440.00 8422.00 to 8595.50 -0.14% 0.82 times
21 Tue Apr 2026 8452.00 8432.00 to 8630.50 -0.93% 0.96 times
20 Mon Apr 2026 8531.50 8413.00 to 8598.00 0.29% 0.73 times

Videos related to: ASTRAZEN announcements Astrazeneca Pharma India Limited announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

ASTRAZEN announcements Astrazeneca Pharma India Limited announcements and dividends declared NSE

 

Back to top